Lyme Diagnostics Ltd. has a unique solution to unambiguously diagnose Lyme disease.
Our solution enables the early and fast testing for Borrelia Burgdorferi, the causative agent of Lyme borreliosis. The method is based on 30 years of research by Dr. Bózsik, who is one of the few still active, first generation Lyme scientists.
The reagent and method used is already tested on tens of thousands of samples. Now we are preparing clinical validation. We are also adjusting the devices with state-of-the-art technology, which will enable 10 times faster investigations.
An investment of € 3.5M would enable us to speed up the process and start providing a service within 2 years. Our lab partner, who has the widest network of laboratories in Europe, is expecting us to increase this speed to market.
To the investor, we can provide a ROI of 214%, and, in case of receiving EU non-returnable funds, our break-even is in the second year of market launch.